These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26779628)

  • 1. Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
    Li MX; Zhao H; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Wei WQ; Zhao DB; Cai JQ
    Tumour Biol; 2016 Jul; 37(7):9301-10. PubMed ID: 26779628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
    Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
    J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.
    Lee YH; Hsia CY; Hsu CY; Huang YH; Lin HC; Huo TI
    World J Surg; 2013 Jun; 37(6):1348-55. PubMed ID: 23467925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Chiang JH; Lee PC; Lee SD
    BMC Gastroenterol; 2010 Dec; 10():146. PubMed ID: 21194431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
    Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
    J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Sheu FY; Lai PL; Yuan RH
    Langenbecks Arch Surg; 2015 Aug; 400(6):725-34. PubMed ID: 26250145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.
    Cai MY; Wang FW; Li CP; Yan LX; Chen JW; Luo RZ; Yun JP; Zeng YX; Xie D
    Chin J Cancer; 2016 Aug; 35(1):80. PubMed ID: 27527497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.
    Zakaria HM; Macshut M; Gaballa NK; Sherif AE; Abdel-Samea ME; Abdel-Samiee M; Marwan I; Yassein T
    Ann Med Surg (Lond); 2020 Jun; 54():47-53. PubMed ID: 32368340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.
    Grat M; Kornasiewicz O; Hołówko W; Lewandowski Z; Zieniewicz K; Paczek L; Krawczyk M
    Transplant Proc; 2013 Jun; 45(5):1899-903. PubMed ID: 23769067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma.
    Liu W; Wang K; Bao Q; Sun Y; Xing BC
    World J Surg Oncol; 2016 Mar; 14():62. PubMed ID: 26936459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
    Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
    J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
    Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
    Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.
    Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Hsia CY; Huo TI
    J Gastrointest Surg; 2013 Apr; 17(4):730-8. PubMed ID: 23188220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus.
    Li MJ; Xie S; Teng YX; Ma L; Li LQ; Xiang BD; Zhong JH
    Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):499-507. PubMed ID: 36975382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.